Key Drivers
- Profit rebound
- Strong liquidity
- High leverage
AIAI Summary
OSCR has moved past the “can it scale?” debate and is now an earnings-quality story: the opportunity is to turn strong revenue, cash flow, and margin gains into durable profits, but investors should watch closely for normalization in reserve development, morbidity, or medical-cost trends that could quickly expose how repeatable this quarter really was.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Profit rebound
- •Strong liquidity
- •High leverage
OSCR's latest quarter showed a sharp turnaround with strong profitability, liquidity, and cash generation, but elevated leverage and a still-mixed valuation keep the risk-reward balanced.
Price Behavior
Key Price Behavior Insights:
- •Higher highs
- •Support hold
- •Volatile rebound
OSCR has turned into a constructive uptrend over the last month, with higher highs and higher lows, but it needs to hold the $30.00–$31.00 support area while facing resistance near $32.75–$33.00 after a volatile drop-and-rebound.
Sharp drop to $26.54 on 2026-08-06 followed by a fast rebound
Sentiment & News
Key News Insights:
- •Record Profitability
- •Higher Guidance
- •Volatile Rally
Oscar Health delivered a major earnings beat with record first-half profitability, 70% revenue growth, and a raised full-year outlook, though the stock's post-rally moves remained choppy.
The update is a clear fundamental positive, but the stock may stay volatile as investors digest the strong run-up and valuation concerns
Similar Companies in Healthcare
Other companies in the same sector with AI ratings